Skip to main content
    S

    Scholar Rock Holding Corp (SRRK)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $44.54
    +1.33 (+3.09%)

    Market Cap: $5.27B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Scholar Rock Holding Corp (SRRK) Financials: Revenue, Profit and Cash Flow

    Updated Nov 10, 2026. Financial statements from company filings, amounts in US dollars.

    Scholar Rock Holding reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$377.94M, operating cash flow was -$300.04M and free cash flow was -$300.64M. The quarter ended Sep 30, 2026 had revenue of $570.00K and net income of -$107.24M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $384.64M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0-100.0%N/AN/AN/A
    Dec 2022$33.19M+76.4%100.0%-404.8%-405.2%
    Dec 2021$18.82M+22.2%100.0%-690.5%-700.5%
    Dec 2020$15.40M-24.8%100.0%-564.0%-561.5%
    Dec 2019$20.49MN/A100.0%-266.2%-248.9%
    Dec 2018$0N/AN/AN/AN/A
    Dec 2017$0-100.0%N/AN/AN/A
    Dec 2016$379.00KN/A-3192.1%-4277.0%-4276.3%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss widened from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$0$0$0$33.19M$18.82M$15.40M$20.49M$0$0$379.00K
    Cost of revenue$0$0$0$0$0$0$0$0$0$12.48M
    Gross profit$0$0$0$33.19M$18.82M$15.40M$20.49M$0$0-$12.10M
    Research and development$208.44M$184.55M$121.90M$124.44M$108.47M$74.06M$54.22M$36.31M$19.94M$12.48M
    Operating income-$384.64M-$252.05M-$171.29M-$134.37M-$129.92M-$86.88M-$54.54M-$50.69M-$25.03M-$16.21M
    Net income-$377.94M-$246.29M-$165.79M-$134.50M-$131.80M-$86.48M-$51.00M-$49.33M-$25.00M-$16.21M
    EBITDAN/AN/AN/A-$125.91M-$126.04M-$85.49MN/A-$50.24M-$24.38M-$15.63M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$570.00K$0$0$0$0$0$0$0$0$0$0$11.66M
    Gross profit$562.00K$0$0-$425.00K$0$0$0-$395.00K$0$0$0-$672.00K
    Operating income-$106.06M-$108.90M-$102.02M-$91.90M-$103.55M-$112.11M-$77.09M-$69.36M-$64.78M-$59.50M-$58.42M-$48.03M
    Net income-$107.24M-$109.90M-$105.51M-$90.97M-$102.22M-$110.03M-$74.72M-$66.45M-$64.48M-$58.51M-$56.85M-$46.13M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, cash and equivalents exceeded total debt of $105.26M by $218.27M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$404.27M$474.92M$311.04M$358.17M$304.44M$388.31M$196.38M$181.34M$61.64M$32.78M
    Current assets$385.15M$451.17M$288.19M$328.02M$265.32M$344.40M$185.17M$177.94M$59.20M$28.50M
    Cash and equivalents$323.53M$177.88M$101.86M$103.28M$212.84M$160.36M$36.31M$115.07M$56.46M$10.03M
    Total liabilities$158.78M$106.29M$85.82M$97.93M$132.37M$127.53M$83.48M$74.71M$5.93M$62.81M
    Short-term debt$5.55M$5.77M$1.33M$0$1.58M$5.37M$1.14M$424.00K$641.00K$647.00K
    Long-term debt$99.71M$50.15M$48.68M$49.74M$48.42M$24.68M$0$24.00K$398.00K$1.02M
    Shareholder equity$245.49M$368.63M$225.22M$260.24M$172.07M$260.77M$112.90M$106.62M-$53.52M-$30.03M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$445.97M$523.54M$535.25M$404.27M$411.72M$340.05M$407.55M$474.92M$179.13M$226.87M$267.29M$311.04M
    Total liabilities$277.30M$269.76M$259.24M$158.78M$166.72M$106.75M$95.22M$106.29M$99.94M$93.25M$84.51M$85.82M
    Cash and equivalents$366.27M$437.09M$430.54M$323.53M$286.77M$152.93M$137.93M$177.88M$76.39M$93.37M$91.98M$101.86M
    Shareholder equity$168.68M$253.78M$276.01M$245.49M$245.00M$233.29M$312.33M$368.63M$79.20M$133.62M$182.77M$225.22M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$300.04M-$200.95M-$145.23M-$132.69M-$126.79M-$60.27M-$63.12M$24.57M-$21.74M-$15.14M
    Capital expenditures$602.00K$98.00K$71.00K$1.06M$5.25M$4.09M$3.12M$1.49M$361.00K$794.00K
    Free cash flow-$300.64M-$201.05M-$145.30M-$133.76M-$132.04M-$64.36M-$66.23M$23.08M-$22.10M-$15.94M
    Investing cash flow$218.69M-$76.06M$41.14M-$171.70M$134.31M-$63.50M-$62.24M-$60.23M$17.66M-$20.32M
    Financing cash flow$228.40M$353.03M$102.57M$194.83M$44.95M$247.82M$48.88M$94.27M$50.50M$1.00M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow-$81.81M-$70.31M-$82.10M-$75.50M-$68.92M-$76.94M-$78.67M-$49.51M-$52.45M-$49.20M-$49.78M-$37.35M
    Capital expenditures$101.00K$1.00K$68.00K$32.00K$84.00K$215.00K$271.00K$22.00K$31.00K$22.00K$23.00K$0
    Free cash flow-$81.91M-$70.31M-$82.17M-$75.53M-$69.01M-$77.16M-$78.95M-$49.53M-$52.49M-$49.22M-$49.81M-$37.35M
    Last 12 quarters

    Frequently Asked Questions About SRRK

    What is Scholar Rock Holding's annual revenue?

    Scholar Rock Holding reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Scholar Rock Holding profitable?

    No. Scholar Rock Holding reported net income of -$377.94M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does SRRK generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$300.04M minus capital expenditures of $602.00K produced free cash flow of -$300.64M.

    How much debt does Scholar Rock Holding have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $99.71M, short-term debt of $5.55M and cash and equivalents of $323.53M.